Enliven Therapeutics
Enliven Therapeutics is a cancer Treatments.
1
Funding Rounds
$85.0m
Money raised
Funding series
Funding Series Analysis
The company Enliven Therapeutics has raised a total of $85m in funding over 1 rounds.
Key Insights:
- Enliven Therapeutics Series B round, January 19, 2022: $85m
Enliven Therapeutics Series B round, January 19, 2022
$85m
Industries
Enliven Therapeutics is active in the following industries:
- Engineering
- Biomedical engineering
- Technology
- Biology
- Oncology
- Pharmaceutical industry
- Drug discovery
- Biotechnology